TOKYO -- Japanese biotech venture AnGes is set to begin a clinical trial of a coronavirus vaccine in July, Nikkei learned Monday, raising hopes that the medication could secure government approval by the end of the year.
Pharmaceuticals
Japan's AnGes aims to release coronavirus vaccine by end of year
Clinical trial to begin in July as firm races to catch up with rivals in US and China
An AnGes researcher works in a company lab developing a DNA vaccine for the coronavirus on May 16. The company was able to move up the start of clinical trials from September to July. (Nikkei Montage/ Source photo by Kyodo and AnGes)
Read Next
Latest on Pharmaceuticals
